EE200200470A - Uued ühendid, meetod nende valmistamiseks ning nende kasutamine - Google Patents

Uued ühendid, meetod nende valmistamiseks ning nende kasutamine

Info

Publication number: EE200200470A
Authority: EE; Estonia
Prior art keywords: preparation; new compounds; compounds; new
Prior art date: 2000-02-25

Application number

EEP200200470A

Other languages

English (en)

Inventor

Bodkin Michael

Eriksson Tomas

Hansen Peter

Hemmerling Martin

Henriksson Krister

Klingstedt Tomas

Pettersson Lars

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-25

Filing date

2001-02-23

Publication date

2003-12-15

2000-02-25 Priority claimed from SE0000620A external-priority patent/SE0000620D0/xx

2000-06-14 Priority claimed from SE0002234A external-priority patent/SE0002234D0/xx

2000-10-31 Priority claimed from SE0003979A external-priority patent/SE0003979D0/xx

2001-02-23 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-12-15 Publication of EE200200470A publication Critical patent/EE200200470A/et

2008-04-15 Publication of EE05001B1 publication Critical patent/EE05001B1/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Immunology (AREA)
Dermatology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Physical Education & Sports Medicine (AREA)
Pulmonology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Virology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Toxicology (AREA)
Tropical Medicine & Parasitology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)

EEP200200470A 2000-02-25 2001-02-23 Heterotsüklilised ühendid, meetod nende valmistamiseks, neid sisaldav ravimkoostis ning nende kasutamine ravis EE05001B1 (et)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
SE0000620A SE0000620D0 (sv)	2000-02-25	2000-02-25	Novel compounds
SE0002234A SE0002234D0 (sv)	2000-06-14	2000-06-14	Novel compounds
SE0003979A SE0003979D0 (sv)	2000-10-31	2000-10-31	Novel Compounds
PCT/SE2001/000403 WO2001062728A1 (en)	2000-02-25	2001-02-23	Novel compounds

Publications (2)

Publication Number	Publication Date
EE200200470A true EE200200470A (et)	2003-12-15
EE05001B1 EE05001B1 (et)	2008-04-15

Family

ID=27354503

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200470A EE05001B1 (et)	2000-02-25	2001-02-23	Heterotsüklilised ühendid, meetod nende valmistamiseks, neid sisaldav ravimkoostis ning nende kasutamine ravis

Country Status (28)

Country	Link
US (3)	US6927222B2 (et)
EP (3)	EP1263724B1 (et)
JP (3)	JP2003523999A (et)
KR (3)	KR20020076338A (et)
CN (3)	CN1187326C (et)
AR (1)	AR029806A1 (et)
AT (2)	ATE280153T1 (et)
AU (3)	AU3630101A (et)
BR (3)	BR0108679A (et)
CA (3)	CA2400434A1 (et)
CO (1)	CO5300399A1 (et)
CZ (1)	CZ20022870A3 (et)
DE (2)	DE60110900T2 (et)
DK (2)	DK1263725T3 (et)
EE (1)	EE05001B1 (et)
ES (2)	ES2227140T3 (et)
HU (1)	HUP0300922A2 (et)
IL (2)	IL151202A0 (et)
IS (1)	IS6520A (et)
MX (3)	MXPA02008243A (et)
NO (3)	NO323584B1 (et)
NZ (2)	NZ520718A (et)
PL (1)	PL358281A1 (et)
PT (2)	PT1263725E (et)
RU (1)	RU2265011C2 (et)
SI (2)	SI1263724T1 (et)
SK (1)	SK12132002A3 (et)
WO (3)	WO2001062728A1 (et)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CO5300399A1 (es)	2000-02-25	2003-07-31	Astrazeneca Ab	Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
AR028948A1 (es) *	2000-06-20	2003-05-28	Astrazeneca Ab	Compuestos novedosos
US7005439B2 (en) *	2000-06-20	2006-02-28	Astrazeneca Ab	Compounds
AR035230A1 (es) *	2001-03-19	2004-05-05	Astrazeneca Ab	Compuestos de bencimidazol, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion farmaceutica, y usos de estos compuestos para la elaboracion de medicamentos
SE0101038D0 (sv) *	2001-03-23	2001-03-23	Astrazeneca Ab	Novel compounds
WO2003020029A1 (en) *	2001-08-30	2003-03-13	Chemocentryx, Inc.	Arylamines as inhibitors of chemokine binding to us28
SE0104251D0 (sv) *	2001-12-14	2001-12-14	Astrazeneca Ab	Novel compounds
TW200303304A (en) *	2002-02-18	2003-09-01	Astrazeneca Ab	Chemical compounds
EP2402309A1 (en) *	2002-05-24	2012-01-04	Millennium Pharmaceuticals, Inc.	CCR9 inhibitors and methods of use thereof
GB0225379D0 (en) *	2002-10-31	2002-12-11	Pfizer Ltd	Therapeutic proline derivatives
US7659305B2 (en)	2002-10-31	2010-02-09	Pfizer Inc.	Therapeutic proline derivatives
GB0402101D0 (en) *	2004-01-30	2004-03-03	Novartis Ag	Organic compounds
SE0400208D0 (sv) *	2004-02-02	2004-02-02	Astrazeneca Ab	Chemical compounds
TW200610761A (en) *	2004-04-23	2006-04-01	Astrazeneca Ab	Chemical compounds
TW200716628A (en) *	2005-03-22	2007-05-01	Astrazeneca Ab	Novel compounds
CA2617127A1 (en) *	2005-08-01	2007-02-08	Astrazeneca Ab	Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases.
TW200738635A (en) *	2005-08-02	2007-10-16	Astrazeneca Ab	New salt
TW200738634A (en) *	2005-08-02	2007-10-16	Astrazeneca Ab	New salt
TW200734305A (en) *	2005-08-02	2007-09-16	Astrazeneca Ab	New salt III
CN101516863A (zh) *	2006-07-18	2009-08-26	阿斯利康(瑞典)有限公司	制备取代的2-乙酰基氨基-烷氧基苯的方法
GB0702456D0 (en)	2007-02-08	2007-03-21	Astrazeneca Ab	New combination
WO2008136754A1 (en) *	2007-05-07	2008-11-13	Astrazeneca Ab	Novel benzyl - 2 -oxo-piperazinyl/ 7-oxo/5-oxa- [1,4] diazepanyl/ 2 -oxo- tetrahydropyrimidinyl derivatives
WO2008150231A1 (en) *	2007-06-08	2008-12-11	Astrazeneca Ab	New heterocyclic compounds for treatment of respiratory, airway or inflammatory disorders
JP5501251B2 (ja)	2008-01-11	2014-05-21	アルバニーモレキュラーリサーチ，インコーポレイテッド	Ｍｃｈ拮抗薬としての（１−アジノン）置換ピリドインドール類
US9625475B2 (en)	2008-09-29	2017-04-18	Abbvie Inc.	Indole and indoline derivatives and methods of use thereof
JP2012504137A (ja)	2008-09-29	2012-02-16	アボット・ラボラトリーズ	インドール誘導体およびインドリン誘導体ならびにそれらの使用方法
WO2011003007A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2011003021A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
EP2448585B1 (en)	2009-07-01	2014-01-01	Albany Molecular Research, Inc.	Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
WO2011003012A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
GB0913345D0 (en)	2009-07-31	2009-09-16	Astrazeneca Ab	New combination 802
WO2011061527A1 (en)	2009-11-17	2011-05-26	Astrazeneca Ab	Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
WO2011073662A1 (en)	2009-12-17	2011-06-23	Astrazeneca Ab	Combination of a benzoxazinone and a further agent for treating respiratory diseases
WO2012088038A2 (en)	2010-12-21	2012-06-28	Albany Molecular Research, Inc.	Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
US8993765B2 (en)	2010-12-21	2015-03-31	Albany Molecular Research, Inc.	Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
GB201021992D0 (en)	2010-12-23	2011-02-02	Astrazeneca Ab	Compound
GB201021979D0 (en)	2010-12-23	2011-02-02	Astrazeneca Ab	New compound
WO2012163848A1 (en)	2011-05-27	2012-12-06	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods and pharmaceutical compositions for the treatment of crohn's disease
GB201209587D0 (en)	2012-05-30	2012-07-11	Takeda Pharmaceutical	Therapeutic compounds
CN104710419B (zh) *	2015-03-18	2017-05-24	中国药科大学	四氢吡啶[4，3‑b]骈吲哚类化合物、其制备方法及医药用途
US11186564B2 (en) *	2016-08-04	2021-11-30	Sunovion Pharmaceuticals Inc.	Dual NAV1.2/5HT2a inhibitors for treating CNS disorders
EP4115885A1 (en)	2021-07-05	2023-01-11	Charité - Universitätsmedizin Berlin	A pharmaceutical composition comprising bay 86-5277 and salts thereof for use in the treatment of viral infections and hyperinflammation

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1220440B (de) *	1962-02-14	1966-07-07	Sanol Arznei Schwarz Gmbh	Verfahren zur Herstellung von Derivaten des 1-(o-Bromphenoxy)-2-hydroxy-3-amino-propans und deren Saeureadditionssalzen
US3577432A (en) *	1968-12-23	1971-05-04	Robins Co Inc A H	1-substituted-3-phenoxypyrrolidines
US4029801A (en) *	1970-09-03	1977-06-14	John Wyeth & Brother Limited	Pharmaceutical compositions and methods of treating hypertension
JPS5511670B1 (et)	1971-07-13	1980-03-26
US3755584A (en) *	1972-04-03	1973-08-28	Abbott Lab	Tranquilizers
FR2190430A1 (en)	1972-06-29	1974-02-01	Ferlux	N-aminomethylhydroxamic acids - with antiinflammatory activity pre-pared by Mannich reaction
US3775584A (en) *	1972-11-30	1973-11-27	D Moerke	Welding gun
US3818017A (en) *	1973-01-04	1974-06-18	Janssen Pharmaceutica Nv	1-{8 1-(2-hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
US3894030A (en) *	1973-01-04	1975-07-08	Janssen Pharmaceutica Nv	1-{8 1-(2-Hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
US4166119A (en)	1978-04-14	1979-08-28	American Hoechst Corporation	Analgesic and tranquilizing spiro[dihydrobenzofuran]piperidines and pyrrolidines
US4264613A (en) *	1979-08-01	1981-04-28	Science Union Et Cie, Societe Francaise De Recherche Medicale	Piperidylbenzimidazolinone compounds
FR2469411A1 (fr) *	1979-11-15	1981-05-22	Science Union & Cie	Nouveaux derives de la piperidylbenzimidazolinone, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
EP0095454A3 (de)	1982-05-13	1985-04-03	Gerot-Pharmazeutika Gesellschaft m.b.H.	Neue kernsubstituierte Pyrogallol-Derivate
JPS59222484A (ja)	1983-06-02	1984-12-14	Kowa Co	テトラヒドロナフチルカルボン酸フエニルエステル誘導体
US5614533A (en) *	1987-03-13	1997-03-25	Bio-Mega/Boehringer Ingelheim Research, Inc.	Substituted pipecolinic acid derivatives as HIV protease inhibitors
DE3723568C2 (de)	1987-07-16	1994-01-27	Siemens Ag	Differenzstromschutzschalter
DE3723648A1 (de) *	1987-07-17	1989-01-26	Sandoz Ag	Indol-derivate, ihre herstellung und sie enthaltende arzneimittel
ES2027897A6 (es)	1991-01-24	1992-06-16	Espanola Prod Quimicos	Procedimiento de preparacion de nuevos derivados de la difenilmetilpiperacina.
IL105716A0 (en)	1992-06-08	1993-09-22	Richter Gedeon Vegyeszet	Aminopropanol derivatives,their preparation and pharmaceutical compositions containing them
AU662434B2 (en)	1992-08-07	1995-08-31	Sankyo Company Limited	Peptides capable of inhibiting the activity of HIV protease, their preparation and their use
US5789402A (en) *	1995-01-17	1998-08-04	Eli Lilly Company	Compounds having effects on serotonin-related systems
US5614523A (en) *	1995-01-17	1997-03-25	Eli Lilly And Company	Compounds having effects on serotonin-related systems
US5741789A (en) *	1995-01-17	1998-04-21	Eli Lilly And Company	Compounds having effects on serotonin-related systems
US5627196A (en) *	1995-01-17	1997-05-06	Eli Lilly And Company	Compounds having effects on serotonin-related systems
US5576321A (en) *	1995-01-17	1996-11-19	Eli Lilly And Company	Compounds having effects on serotonin-related systems
ZA9610738B (en)	1995-12-22	1997-06-24	Warner Lambert Co	Subtype selective nmda receptor ligands and the use thereof
DE19703131A1 (de)	1997-01-29	1998-07-30	Bayer Ag	Verwendung von Chinoxalin in Dreier-Kombination mit Protease-Inhibitoren und Reverse Transkriptaseinhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
IL125658A0 (en) *	1997-08-18	1999-04-11	Hoffmann La Roche	Ccr-3 receptor antagonists
BR9814645A (pt)	1997-11-18	2001-07-31	Teijin Ltd	Derivados de amina cìclica e seu uso como medicamentos
DE19755268A1 (de)	1997-12-12	1999-06-17	Merck Patent Gmbh	Benzamidinderivate
FR2780057B1 (fr)	1998-06-18	2002-09-13	Sanofi Sa	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
AU2057200A (en)	1998-12-18	2000-07-03	Du Pont Pharmaceuticals Company	N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU2482100A (en)	1998-12-18	2000-07-03	Du Pont Pharmaceuticals Company	N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU2942000A (en)	1999-03-11	2000-09-28	Banyu Pharmaceutical Co., Ltd.	Novel piperidine derivatives
PL350904A1 (en) *	1999-03-26	2003-02-10	Astrazeneca Ab	Novel compounds
DE19922316A1 (de)	1999-05-14	2000-11-16	Goedecke Ag	Verfahren zur Herstellung von (R)-N-[(Benzo[b]furan-2-yl)-alkoxycarbonyl]-tryptophanalkylestern
US7125895B1 (en)	1999-05-14	2006-10-24	Bristol-Myers Squibb Pharma Research Labs, Inc.	Cyclic amine derivatives and their uses
SE9902987D0 (sv)	1999-08-24	1999-08-24	Astra Pharma Prod	Novel compounds
FR2802533B1 (fr)	1999-12-17	2002-02-15	Sanofi Synthelabo	Phenoxypropanolamines, leur preparation et leur application en therapeutique
DE60033964T2 (de)	1999-12-17	2007-11-29	Sanofi-Aventis	Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung
CO5300399A1 (es)	2000-02-25	2003-07-31	Astrazeneca Ab	Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
GB0011838D0 (en)	2000-05-17	2000-07-05	Astrazeneca Ab	Chemical compounds
AR028948A1 (es)	2000-06-20	2003-05-28	Astrazeneca Ab	Compuestos novedosos
US7005439B2 (en)	2000-06-20	2006-02-28	Astrazeneca Ab	Compounds
AR028947A1 (es) *	2000-06-20	2003-05-28	Astrazeneca Ab	Compuestos novedosos
SE0100903D0 (sv)	2001-03-15	2001-03-15	Astrazeneca Ab	Compounds
SE0101038D0 (sv)	2001-03-23	2001-03-23	Astrazeneca Ab	Novel compounds

2001
- 2001-02-22 CO CO01014299A patent/CO5300399A1/es not_active Application Discontinuation
- 2001-02-23 ES ES01908558T patent/ES2227140T3/es not_active Expired - Lifetime
- 2001-02-23 WO PCT/SE2001/000403 patent/WO2001062728A1/en not_active Ceased
- 2001-02-23 BR BR0108679-0A patent/BR0108679A/pt not_active IP Right Cessation
- 2001-02-23 HU HU0300922A patent/HUP0300922A2/hu unknown
- 2001-02-23 DE DE60110900T patent/DE60110900T2/de not_active Expired - Fee Related
- 2001-02-23 BR BR0108677-4A patent/BR0108677A/pt not_active IP Right Cessation
- 2001-02-23 AU AU36301/01A patent/AU3630101A/en not_active Abandoned
- 2001-02-23 MX MXPA02008243A patent/MXPA02008243A/es unknown
- 2001-02-23 SI SI200130366T patent/SI1263724T1/xx unknown
- 2001-02-23 PT PT01908558T patent/PT1263725E/pt unknown
- 2001-02-23 CN CNB018084842A patent/CN1187326C/zh not_active Expired - Fee Related
- 2001-02-23 SI SI200130239T patent/SI1263725T1/xx unknown
- 2001-02-23 KR KR1020027011128A patent/KR20020076338A/ko not_active Withdrawn
- 2001-02-23 AT AT01908558T patent/ATE280153T1/de not_active IP Right Cessation
- 2001-02-23 PL PL01358281A patent/PL358281A1/xx not_active Application Discontinuation
- 2001-02-23 RU RU2002122100/04A patent/RU2265011C2/ru not_active IP Right Cessation
- 2001-02-23 PT PT01908557T patent/PT1263724E/pt unknown
- 2001-02-23 BR BR0108678-2A patent/BR0108678A/pt not_active IP Right Cessation
- 2001-02-23 EP EP01908557A patent/EP1263724B1/en not_active Expired - Lifetime
- 2001-02-23 AR ARP010100842A patent/AR029806A1/es not_active Application Discontinuation
- 2001-02-23 DE DE60106581T patent/DE60106581T2/de not_active Expired - Fee Related
- 2001-02-23 KR KR1020027011129A patent/KR20020075450A/ko not_active Withdrawn
- 2001-02-23 MX MXPA02008241A patent/MXPA02008241A/es active IP Right Grant
- 2001-02-23 CZ CZ20022870A patent/CZ20022870A3/cs unknown
- 2001-02-23 US US10/204,789 patent/US6927222B2/en not_active Expired - Fee Related
- 2001-02-23 NZ NZ520718A patent/NZ520718A/en unknown
- 2001-02-23 AU AU36299/01A patent/AU783496B2/en not_active Ceased
- 2001-02-23 EP EP01908558A patent/EP1263725B1/en not_active Expired - Lifetime
- 2001-02-23 AU AU36300/01A patent/AU783475B2/en not_active Ceased
- 2001-02-23 CN CNB018084125A patent/CN1229343C/zh not_active Expired - Fee Related
- 2001-02-23 CA CA002400434A patent/CA2400434A1/en not_active Abandoned
- 2001-02-23 MX MXPA02008244A patent/MXPA02008244A/es active IP Right Grant
- 2001-02-23 JP JP2001561737A patent/JP2003523999A/ja not_active Withdrawn
- 2001-02-23 NZ NZ520719A patent/NZ520719A/en unknown
- 2001-02-23 JP JP2001561736A patent/JP2003523998A/ja not_active Withdrawn
- 2001-02-23 IL IL15120201A patent/IL151202A0/xx unknown
- 2001-02-23 US US10/204,790 patent/US6943188B2/en not_active Expired - Fee Related
- 2001-02-23 WO PCT/SE2001/000405 patent/WO2001062757A1/en not_active Ceased
- 2001-02-23 US US10/204,754 patent/US6951874B2/en not_active Expired - Fee Related
- 2001-02-23 AT AT01908557T patent/ATE295833T1/de not_active IP Right Cessation
- 2001-02-23 CA CA002400435A patent/CA2400435A1/en not_active Abandoned
- 2001-02-23 KR KR1020027011127A patent/KR100752033B1/ko not_active Expired - Fee Related
- 2001-02-23 IL IL15120801A patent/IL151208A0/xx unknown
- 2001-02-23 DK DK01908558T patent/DK1263725T3/da active
- 2001-02-23 EP EP01908559A patent/EP1263760A1/en not_active Withdrawn
- 2001-02-23 DK DK01908557T patent/DK1263724T3/da active
- 2001-02-23 CN CN01808426A patent/CN1426412A/zh active Pending
- 2001-02-23 SK SK1213-2002A patent/SK12132002A3/sk unknown
- 2001-02-23 WO PCT/SE2001/000404 patent/WO2001062729A1/en not_active Ceased
- 2001-02-23 EE EEP200200470A patent/EE05001B1/et not_active IP Right Cessation
- 2001-02-23 CA CA002400293A patent/CA2400293A1/en not_active Abandoned
- 2001-02-23 JP JP2001562539A patent/JP2003524011A/ja active Pending
- 2001-02-23 ES ES01908557T patent/ES2241796T3/es not_active Expired - Lifetime
2002
- 2002-08-19 NO NO20023934A patent/NO323584B1/no unknown
- 2002-08-19 NO NO20023933A patent/NO20023933L/no not_active Application Discontinuation
- 2002-08-19 NO NO20023932A patent/NO20023932L/no not_active Application Discontinuation
- 2002-08-22 IS IS6520A patent/IS6520A/is unknown

Also Published As

Publication number	Publication date
ATE295833T1 (de)	2005-06-15
BR0108677A (pt)	2002-11-12
EP1263725B1 (en)	2004-10-20
CO5300399A1 (es)	2003-07-31
AU783475B2 (en)	2005-10-27
EP1263724A1 (en)	2002-12-11
SI1263724T1 (en)	2005-10-31
AU3630101A (en)	2001-09-03
JP2003523999A (ja)	2003-08-12
CN1426393A (zh)	2003-06-25
NO20023932D0 (no)	2002-08-19
KR20020076338A (ko)	2002-10-09
EE05001B1 (et)	2008-04-15
CA2400293A1 (en)	2001-08-30
EP1263725A1 (en)	2002-12-11
CN1187326C (zh)	2005-02-02
CN1229343C (zh)	2005-11-30
CA2400435A1 (en)	2001-08-30
BR0108679A (pt)	2002-11-26
US20030158225A1 (en)	2003-08-21
NO20023933D0 (no)	2002-08-19
MXPA02008243A (es)	2002-11-29
IL151208A0 (en)	2003-04-10
CN1426394A (zh)	2003-06-25
MXPA02008241A (es)	2002-11-29
RU2265011C2 (ru)	2005-11-27
IL151202A0 (en)	2003-04-10
WO2001062757A1 (en)	2001-08-30
DE60106581T2 (de)	2005-09-15
ATE280153T1 (de)	2004-11-15
PL358281A1 (en)	2004-08-09
PT1263725E (pt)	2005-02-28
NO20023933L (no)	2002-10-24
NZ520719A (en)	2004-06-25
ES2241796T3 (es)	2005-11-01
IS6520A (is)	2002-08-22
SK12132002A3 (sk)	2003-06-03
US6927222B2 (en)	2005-08-09
DE60110900D1 (de)	2005-06-23
DK1263725T3 (da)	2005-01-17
DE60106581D1 (de)	2004-11-25
AR029806A1 (es)	2003-07-16
EP1263760A1 (en)	2002-12-11
CA2400434A1 (en)	2001-08-30
WO2001062729A1 (en)	2001-08-30
NZ520718A (en)	2004-09-24
NO20023934D0 (no)	2002-08-19
US6943188B2 (en)	2005-09-13
NO20023932L (no)	2002-10-24
DK1263724T3 (da)	2005-08-15
US20030144267A1 (en)	2003-07-31
DE60110900T2 (de)	2006-04-27
KR100752033B1 (ko)	2007-08-28
AU3629901A (en)	2001-09-03
KR20020075450A (ko)	2002-10-04
AU3630001A (en)	2001-09-03
JP2003523998A (ja)	2003-08-12
WO2001062728A1 (en)	2001-08-30
MXPA02008244A (es)	2002-11-29
HUP0300922A2 (hu)	2003-07-28
SI1263725T1 (en)	2005-02-28
JP2003524011A (ja)	2003-08-12
NO20023934L (no)	2002-10-07
HK1048990A1 (en)	2003-04-25
ES2227140T3 (es)	2005-04-01
CN1426412A (zh)	2003-06-25
US20030149047A1 (en)	2003-08-07
BR0108678A (pt)	2002-12-03
NO323584B1 (no)	2006-06-11
US6951874B2 (en)	2005-10-04
AU783496B2 (en)	2005-11-03
PT1263724E (pt)	2005-09-30
RU2002122100A (ru)	2004-01-10
KR20020079912A (ko)	2002-10-19
EP1263724B1 (en)	2005-05-18
CZ20022870A3 (cs)	2003-02-12

Publication	Publication Date	Title
EE200200704A (et)	2004-08-16	Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
EE200200470A (et)	2003-12-15	Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
EE05223B1 (et)	2009-10-15	Triasoloprimidiini hendid, meetod nende valmistamiseks ning nende kasutamine
EE200300544A (et)	2004-02-16	4-anilinokinoliin-3-karboksamiidid, nende kasutamine ning valmistamine
EE200100437A (et)	2002-12-16	C-21 modifitseeritud epotioloonid, nende valmistamise meetod ning kasutamine
EE200100574A (et)	2003-02-17	Uued ühendid, nende valmistamise meetod ning kasutamine
EE200300400A (et)	2003-12-15	Pürimidiiniühendid, nende valmistamismeetod ning kasutamine
CY2007029I1 (el)	2009-11-04	Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
DK1180518T3 (da)	2007-05-21	5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
PL364767A1 (en)	2004-12-13	Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
EE200300151A (et)	2003-06-16	Ravimitena kasutatavad antikolinergikumid ning meetodid nende valmistamiseks
AR028110A1 (es)	2003-04-23	Nuevo proceso
NO20030012L (no)	2003-03-03	Fremgangsmåte for fremstilling av substituerte oktanoylamider
EE200300245A (et)	2003-08-15	Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine
FI20011621A0 (fi)	2001-08-09	Menetelmä sitalopraamin valmistamiseksi
HUP0302295A3 (en)	2007-03-28	Thienodibenzoazulene derivatives, process for their preparation and use thereof
EE200200697A (et)	2004-08-16	Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
DE10196082T1 (de)	2003-03-13	FLIP-CHIP-Montageverfahren
EE200100573A (et)	2003-02-17	Uued ühendid, nende valmistamise meetod ning kasutamine
EE200300060A (et)	2004-12-15	Polaarsete rühmadega perfluoroalküülrühma sisaldavad kompleksid, nende valmistamismeetod ja kasutamine
NO20030515L (no)	2003-03-31	Fremgangsmåte for fremstilling av dinapsolin
HUP0100146A3 (en)	2003-07-28	3-(1-hydroxy-pentylidene)-5-nitro-3h-benzofuran-2-one, process for its preparation and use thereof
EE200000752A (et)	2002-04-15	Alfa-D-ksüloosiühendid, nende valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon
EE200200410A (et)	2003-12-15	Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid
NO20023702D0 (no)	2002-08-06	Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder

Legal Events

Date	Code	Title	Description
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2009-10-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20090223